FDA Approved: DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium (Sandoz).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception
• Neural Tube Defects Prevention

Drugs mentioned

• DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM (Drospirenone/ethinyl estradiol/levomefolate calcium)
• LEVOMEFOLATE CALCIUM (Levomefolate calcium)

Snippet

SUPPL AP for DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM (DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM)